Lexicon Pharmaceutcl (LXRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.7308 +0.0620 (+9.27%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.7201 -0.0107 (-1.46%) 19:45 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | LXRX | INBX | BIOA | ||
| Company | Lexicon Pharmaceutcl | Inhibrx Biosciences Inc | Bioage Labs Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.6709 | 11.59 | 4.31 | ||
| High | 0.7371 | 12.52 | 4.34 | ||
| Low | 0.6500 | 11.43 | 4.08 | ||
| Last | 0.7308 | 12.33 | 4.20 | ||
| Change | +0.0620 | +0.61 | -0.13 | ||
| % Change | +9.27% | +5.20% | -3.00% | ||
| Volume | 5,704,600 | 103,100 | 194,000 | ||
| 20-Day Average Volume | 8,708,875 | 136,625 | 374,735 | ||
| Previous Close | 0.6688 | 11.72 | 4.33 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.5659 | 12.12 | 3.78 | ||
| 20-Day Raw Stochastic | 84.46% | 45.52% | 82.50% | ||
| 20-Day Relative Strength | 62.49% | 47.25% | 50.96% | ||
| Weighted Alpha | -51.47 | -23.18 | -41.96 | ||
| Today's Opinion | 24% Sell | 88% Sell | N/A | ||
| Previous Opinion | 24% Sell | 100% Sell | N/A | ||
| Last Month's Opinion | 80% Sell | 48% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.78% since 04/23/25 | +1.40% since 04/23/25 | +1.69% since 04/23/25 | ||
| Low | 0.6500 on 04/30/25 | 11.13 on 04/29/25 | 4.00 on 04/25/25 | ||
| High | 0.7990 on 04/25/25 | 12.82 on 04/25/25 | 4.48 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +28.10% since 03/28/25 | -12.68% since 03/28/25 | +9.95% since 03/28/25 | ||
| Low | 0.3600 on 04/07/25 | 10.81 on 04/11/25 | 2.88 on 04/09/25 | ||
| High | 0.7990 on 04/25/25 | 14.40 on 03/31/25 | 4.48 on 04/28/25 | ||
| 3-Month | |||||
| %Chg | -10.81% since 01/30/25 | -9.00% since 01/30/25 | -12.13% since 01/30/25 | ||
| Low | 0.2800 on 03/03/25 | 10.81 on 04/11/25 | 2.88 on 04/09/25 | ||
| High | 0.9744 on 02/18/25 | 15.29 on 03/13/25 | 4.89 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | -62.52% since 10/30/24 | -24.31% since 10/30/24 | -82.95% since 10/30/24 | ||
| Low | 0.2800 on 03/03/25 | 10.81 on 04/11/25 | 2.88 on 04/09/25 | ||
| High | 1.3800 on 11/01/24 | 17.41 on 11/12/24 | 24.66 on 10/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 164,683 | 169,659 | 155,230 | ||
| Shares Outstanding, K | 246,237 | 14,476 | 35,850 | ||
| Annual Sales | 31,080,000 | 200,000 | 0 | ||
| Annual Net Income | -200,400,000 | 1,687,570,000 | -71,110,000 | ||
| Last Quarter Sales | 26,550,000 | 100,000 | 0 | ||
| Last Quarter Net Income | -33,770,000 | -77,300,000 | -23,410,000 | ||
| 60-Month Beta | 1.02 | N/A | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 03/06/25 | -3.09 on 03/17/25 | -6.70 on 11/07/24 | ||
| Latest Earnings Date | 05/01/25 | 06/16/25 | 06/19/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||